Phase 3 Study Investigating Ibrutinib In Older CLL Patients
Jeff Sharman, MD, Director of Research, Willamette Valley Cancer Institute, Medical Director of Hematology Research, The US Oncology Network, discusses Phase 3 Study Investigating Ibrutinib In Older C...
Author: obr
Added: 01/15/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts